Investors who lost money on Neumora Therapeutics, Inc.(NMRA) should contact Levi & Korsinsky about pending Class Action – NMRA

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128703&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

March 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IAS

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Integral Ad Science Holding Corp. (NASDAQ:IAS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/integral-ad-science-lawsuit-submission-form?prid=128700&wire=1 or contact Joseph E. Levi, Esq. via email at

Napco Security Technologies, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Napco Security Technologies, Inc. (NSSC)

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Napco Security Technologies, Inc. ("Napco Security Technologies, Inc.") (NASDAQ:NSSC) concerning possible violations of federal securities laws. On February 3, 2025, news website Investing.com published an article entitled "NAPCO Security stock tumbles after

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 18, 2025 in FTAI Aviation Lawsuit – FTAI

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128707&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Filed Against ESSA Pharma Inc. (EPIX) – March 25, 2025 Deadline to Join – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128704&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

February 18, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against APLT

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128702&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 14, 2025 in MGP Ingredients, Inc. Lawsuit – MGPI

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=128701&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Filed Against Cardlytics, Inc. (CDLX) – March 25, 2025 Deadline to Join – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=128699&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Jan De Witte joins GHO Capital as Operating Partner

Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Jan

CleverTap Recognized in Latest GartnerĀ® Magic Quadrant™ for Personalization Engines

CleverTap, the all-in-one engagement platform, today announced that they have been positioned by Gartner®as a Niche Playerin the Magic Quadrant™for personalization engines. The evaluation was based on specific criteria that analyzed the company's overall Completeness of Vision and Ability to Execute. https://mma.prnewswire.com/media/2617509/CleverTap_and_Gartner.jpg This recognition reflects the company's strengths in delivering personalized customer experiences, its innovative

Scroll to Top